BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6670053)

  • 1. Overall evaluation of treatment modalities for heroin addiction in a toxicology unit.
    Ledda F; Blandina P; Botti P; Caramelli L; Fantozzi R; Masini E; Moroni F; Peruzzi S; Zorn AM; Mannaioni PF
    Subst Alcohol Actions Misuse; 1983; 4(4):283-304. PubMed ID: 6670053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.
    Agren H
    Acta Psychiatr Scand Suppl; 1986; 327():91-113. PubMed ID: 3529831
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating heroin addiction: comparison of methadone therapy, hospital therapy without methadone, and therapeutic community.
    Vidjak N
    Croat Med J; 2003 Feb; 44(1):59-64. PubMed ID: 12590430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
    Gerra G; Marcato A; Caccavari R; Fontanesi B; Delsignore R; Fertonani G; Avanzini P; Rustichelli P; Passeri M
    J Subst Abuse Treat; 1995; 12(1):35-41. PubMed ID: 7752296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone maintenance and clonidine detoxification in the treatment of opiate addicts in Israel: suggesting evidence for cultural differences in the effectiveness of treatment modalities for opiate addiction.
    ShahamY ; Shufman ; Scher ; Barel ; Zlotogorski ; Cohen
    Isr J Psychiatry Relat Sci; 1991; 28(3):45-57. PubMed ID: 1666067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
    Negus SS
    J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are substitution practices indicated in withdrawal within the framework of health care of drug addicts and according to what modalities?].
    Lauzon P
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():87-8. PubMed ID: 7880036
    [No Abstract]   [Full Text] [Related]  

  • 8. From IM morphine to PO methadone.
    Strauss A
    West J Med; 1980 Dec; 133(6):520. PubMed ID: 7467309
    [No Abstract]   [Full Text] [Related]  

  • 9. Methadone and naltrexone in the treatment of heroin dependence.
    Greenstein RA; Resnick RB; Resnick E
    Psychiatr Clin North Am; 1984 Dec; 7(4):671-9. PubMed ID: 6522309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy in overdose and withdrawal syndrome in heroin addicts].
    Arrizabalaga Cuesta C; Zulaica D
    Rev Enferm; 1985 Feb; 8(78):23-5. PubMed ID: 3845677
    [No Abstract]   [Full Text] [Related]  

  • 11. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I; Pani PP; Pacini M; Perugi G
    J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does pregnancy affect outcome of methadone maintenance treatment?
    Crandall C; Crosby RD; Carlson GA
    J Subst Abuse Treat; 2004 Jun; 26(4):295-303. PubMed ID: 15182894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphine intoxication and abstinence].
    Anggård E
    Lakartidningen; 1977 Nov; 74(48):4305-9. PubMed ID: 592916
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of methadone in the treatment of narcotic addiction].
    Tiljak H
    Lijec Vjesn; 1998 May; 120(5):125-31. PubMed ID: 9748791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical aspects of opiate addiction].
    Mannaioni PF; Ledda F; Blandina P; Botti P; Caramelli L; Fantozzi R; Masini E; Moroni F; Peruzzi S; Zorn AM
    Ann Ist Super Sanita; 1982; 18(4):755-7. PubMed ID: 7188533
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
    Binder T; Vavrinková B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.